KBC Group NV Boosts Stock Holdings in Dolby Laboratories, Inc. (NYSE:DLB)

KBC Group NV boosted its stake in Dolby Laboratories, Inc. (NYSE:DLB) by 56.4% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,476 shares of the electronics maker’s stock after purchasing an additional 893 shares during the quarter. KBC Group NV’s holdings in Dolby Laboratories were worth $193,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Fifth Third Bancorp lifted its holdings in shares of Dolby Laboratories by 82.7% in the 4th quarter. Fifth Third Bancorp now owns 360 shares of the electronics maker’s stock valued at $28,000 after acquiring an additional 163 shares during the last quarter. Nisa Investment Advisors LLC lifted its stake in shares of Dolby Laboratories by 436.2% in the 4th quarter. Nisa Investment Advisors LLC now owns 370 shares of the electronics maker’s stock valued at $29,000 after purchasing an additional 301 shares during the last quarter. GAMMA Investing LLC boosted its holdings in shares of Dolby Laboratories by 207.5% in the 4th quarter. GAMMA Investing LLC now owns 778 shares of the electronics maker’s stock worth $61,000 after purchasing an additional 525 shares during the period. First Horizon Advisors Inc. increased its position in shares of Dolby Laboratories by 22.7% during the 3rd quarter. First Horizon Advisors Inc. now owns 790 shares of the electronics maker’s stock valued at $60,000 after purchasing an additional 146 shares during the last quarter. Finally, Prospera Private Wealth LLC bought a new position in shares of Dolby Laboratories during the 3rd quarter valued at approximately $93,000. Institutional investors own 58.56% of the company’s stock.

Dolby Laboratories Price Performance

NYSE DLB opened at $84.52 on Wednesday. The company has a market cap of $8.07 billion, a price-to-earnings ratio of 31.07 and a beta of 0.98. The stock’s fifty day moving average price is $79.51 and its 200 day moving average price is $75.75. Dolby Laboratories, Inc. has a 1 year low of $66.35 and a 1 year high of $89.66.

Dolby Laboratories Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, February 19th. Shareholders of record on Tuesday, February 11th will be given a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a yield of 1.56%. The ex-dividend date of this dividend is Tuesday, February 11th. Dolby Laboratories’s dividend payout ratio is currently 48.53%.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on DLB. Barrington Research reissued an “outperform” rating and issued a $100.00 price objective on shares of Dolby Laboratories in a research report on Monday, January 27th. Rosenblatt Securities reiterated a “buy” rating and issued a $100.00 price target on shares of Dolby Laboratories in a report on Thursday, January 30th. Finally, StockNews.com cut Dolby Laboratories from a “strong-buy” rating to a “buy” rating in a report on Friday, January 31st.

Insiders Place Their Bets

In other Dolby Laboratories news, SVP John D. Couling sold 7,000 shares of the stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $80.50, for a total transaction of $563,500.00. Following the transaction, the senior vice president now owns 106,806 shares in the company, valued at approximately $8,597,883. This represents a 6.15 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CAO Ryan Nicholson sold 10,500 shares of the stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $80.18, for a total value of $841,890.00. Following the transaction, the chief accounting officer now owns 24,364 shares in the company, valued at $1,953,505.52. This trade represents a 30.12 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 175,917 shares of company stock valued at $14,272,939. Company insiders own 38.39% of the company’s stock.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.